1. Home
  2. RAIL vs ZNTL Comparison

RAIL vs ZNTL Comparison

Compare RAIL & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FreightCar America Inc.

RAIL

FreightCar America Inc.

HOLD

Current Price

$13.54

Market Cap

186.6M

Sector

Industrials

ML Signal

HOLD

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

HOLD

Current Price

$2.41

Market Cap

162.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAIL
ZNTL
Founded
1901
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Railroads
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.6M
162.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RAIL
ZNTL
Price
$13.54
$2.41
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$6.60
AVG Volume (30 Days)
134.0K
844.7K
Earning Date
03-11-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
$513,120,000.00
$26,865,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18.34
N/A
P/E Ratio
$5.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.31
$1.01
52 Week High
$13.74
$3.95

Technical Indicators

Market Signals
Indicator
RAIL
ZNTL
Relative Strength Index (RSI) 67.03 49.28
Support Level $11.41 $2.21
Resistance Level $12.87 $2.51
Average True Range (ATR) 0.82 0.28
MACD 0.13 -0.09
Stochastic Oscillator 90.35 20.83

Price Performance

Historical Comparison
RAIL
ZNTL

About RAIL FreightCar America Inc.

FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. The company has two segments: The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and rebuilds, while the Aftermarket segment includes the selling of forged, cast and fabricated railcar parts and supplies for all railcar types, and provides aftermarket services including safety training, railcar inspections, and preventative maintenance. The company's revenue is predominantly derived from its Manufacturing segment.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: